§ 13F · FUND PROFILE
Trails Edge Capital Partners, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 23Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$404.7T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | ACAD | ACADIA PHARMACEUTICALS INC | 1.42M | $37.9T | 9.4% | NEW |
| 2 | BRD1EUR | MIND MEDICINE MINDMED INC | 2.57M | $34.4T | 8.5% | NEW |
| 3 | PCVX | VAXCYTE INC | 737K | $34.0T | 8.4% | NEW |
| 4 | NRIX | NURIX THERAPEUTICS INC | 1.74M | $33.1T | 8.2% | NEW |
| 5 | LBRX | LB PHARMACEUTICALS INC | 1.40M | $31.1T | 7.7% | NEW |
| 6 | XENE | XENON PHARMACEUTICALS INC | 597K | $26.8T | 6.6% | NEW |
| 7 | IMCR | IMMUNOCORE HLDGS PLC | 683K | $23.7T | 5.9% | NEW |
| 8 | RCUS | ARCUS BIOSCIENCES INC | 916K | $21.8T | 5.4% | NEW |
| 9 | TYRA | TYRA BIOSCIENCES INC | 700K | $18.4T | 4.5% | NEW |
| 10 | NGNE | NEUROGENE INC | 785K | $16.2T | 4.0% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE TRAILS SIGNAL
AC read
Trails Edge Capital Partners, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed